NCT06744907View on ClinicalTrials.gov

Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions
Spinal Fusion
Interventions
BIOLOGICAL

10% Povidone-Iodine Arm

A second application of surgical antisepsis with a topical povidone-iodine in the subdermal layer after making an incision.

PROCEDURE

Saline Arm

An application of saline in the subdermal layer after making an incision.

Trial Locations (1)

44308

RECRUITING

Akron Children's Hospital, Akron

All Listed Sponsors
lead

Akron Children's Hospital

OTHER

NCT06744907 - Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion | Biotech Hunter | Biotech Hunter